medical device guru

Ibuprofen Increases Cardiovascular Risk 

Cardiovascular / Cardiology March 28, 2017

When nonsteroidal anti-inflammatory medications such as ibuprofen (Motrin, Advil) and naproxen sodium (Aleve) first hit the market, they were heralded as an attractive alternative to aspirin for tackling aches and pains, as they were thought to be gentler on the digestive tract. But in recent years, these medications, which are used for everything from arthritis to headaches and back pain, have begun to raise serious concerns about their off-target effects, particularly on the heart.


The most recent evidence was released earlier this month when a study from Copenhagen University Hospital in Denmark showed that people taking ibuprofen for a period of less than 30 days raised their risk of sudden cardiac arrest—when the heart suddenly stops pumping blood—by 31 percent in the month that followed, compared to those who didn’t take the painkiller. People who took a prescription NSAID called diclofenac had a 50 percent higher risk of sudden cardiac arrest. To reach their conclusion, the researchers analyzed 29,000 cases of cardiac arrest between 2001 and 2010, examining the use of medications in the previous month.

In another recent study, Chinese researchers found that NSAIDs increased the risk of a heart attack three-fold if they were taken orally during a respiratory infection, and much higher if by intravenous infusion. Colds and flu heighten inflammation generally, and the use of NSAIDs to reduce inflammation was previously thought to be beneficial. However, something else on top of that appears to amplify the risk of a cardiac event.

The problem may stem from the fact that NSAIDs like ibuprofen target an enzyme known as COX-2, which is responsible for pain and inflammation. However the enzyme also plays a role in regulating heart function. How this drug class hurts the heart isn’t fully known, but it may cause arteries to constrict, cause the retention of fluid, raise blood pressure or promote clot formation.

Concerns about NSAIDs and the heart are not new. In 2005 the FDA added a boxed warning about a heightened heart risk to drug labels. Accumulating data prompted the agency to strengthen the warnings in 2015.

Read More – Source: NSAIDs and Cardiovascular Risk – Cleveland HeartLab, Inc.

AUTHOR - Authorship Credit Noted Above
Search our current open opportunities to take your first step to success in Medical Device and Healthcare IT today. Focusing on you and your career is our Job, now it’s time for you to find yours. Let’s get started.